Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: insights from a randomized trial.

Authors

Andrew F. Shorr, George Washington University
Bengt I. Eriksson, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden
Amir K. Jaffer, University of Miami
John J. Smith, Biostatistics, Adaptive Plus, LLC, Durham, NC

Document Type

Journal Article

Publication Date

8-2012

Journal

Journal of Thrombosis and Haemostasis

Volume

Volume 10, Issue 8

Inclusive Pages

1515-1520

Keywords

Anticoagulants--administration & dosage; Enoxaparin--administration & dosage; Hirudins--administration & dosage; Postoperative Hemorrhage--prevention & control; Renal Insufficiency; Chronic--complications; Thrombosis--prevention & control

APA Citation

Shorr, A. F., Eriksson, B. I., Jaffer, A. K., & Smith, J. (2012). Impact of stage 3B chronic kidney disease on thrombosis and bleeding outcomes after orthopedic surgery in patients treated with desirudin or enoxaparin: Insights from a randomized trial. Journal of Thrombosis and Haemostasis, 10(8), 1515-1520.

Peer Reviewed

1